Anika Therapeutics Inc. (ANIK)
NASDAQ · Healthcare
Anika Therapeutics Inc. Shareholder Equity 2009–2025
Anika Therapeutics Inc. annual shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Anika Therapeutics Inc. shareholder equity as of December 31, 2025: 143.5M, a 6.83% decrease year-over-year.
- Anika Therapeutics Inc. shareholder equity for 2025 were 143.5M, a 6.83% decrease from 2024.
- Anika Therapeutics Inc. shareholder equity for 2024 were 154.0M, a 27.45% decrease from 2023.
- Anika Therapeutics Inc. shareholder equity for 2023 were 212.3M, a 25.67% decrease from 2022.
- Anika Therapeutics Inc. shareholder equity for 2022 were 285.6M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Anika Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $143 |
| 2024 | $154 |
| 2023 | $212 |
| 2022 | $286 |
| 2021 | $287 |
| 2020 | $272 |
| 2019 | $288 |
| 2018 | $264 |
| 2017 | $263 |
| 2016 | $223 |
| 2015 | $211 |
| 2014 | $178 |
| 2013 | $136 |
| 2012 | $109 |
| 2011 | $95 |
Anika Therapeutics Inc. Shareholder Equity — FAQ
Anika Therapeutics Inc. (ANIK) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ANIK's shareholder equity history?
The chart and table above show Anika Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.